SCHEMBL3155166

SCHEMBL3155166

CCCNc1ccc(Nc2ncnc(OC3CCN(OC(=O)OC(C)C)CC3)c2C#N)cn1

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 15/20 0.46
ACACB O00763 4/20 0.37
TBK1 Q9UHD2 1/20 0.36
CYP2C9 P11712 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388757 0.90 GPR119 (0.58) GPR119CYP2C9
SCHEMBL3164490 0.88 GPR119 (0.47) GPR119ACACBCYP2C9
SCHEMBL3155044 0.85 GPR119 (0.50) GPR119ACACBCYP2C9
SCHEMBL3168213 0.82 GPR119 (0.57) GPR119CYP2C9
SCHEMBL3257673 0.80 GPR119 (0.48) GPR119ACACBCYP2C9
SCHEMBL3175060 0.79 GPR119 (0.49) GPR119CYP2C9
SCHEMBL3164053 0.78 GPR119 (0.50) GPR119CYP2C9
SCHEMBL3155188 0.78 GPR119 (0.48) GPR119CYP2C9
SCHEMBL389422 0.77 GPR119 (0.59) GPR119CYP2C9
SCHEMBL3155068 0.77 GPR119 (0.52) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644357-B9 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2010-03-24 EP claimed
EP-1644357-B1 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2007-12-12 EP claimed